FDA 510(k) Cleared · Neurology

Uncover autonomic & hidden disorders.

Detect syncope, orthostatic tachycardia syndrome (POTS), and autonomic dysfunction with standardized, reproducible testing protocols.

VitalScan ANS+ diagnostic device
Neurology Conditions

What VitalScan helps you identify.

Syncope

ANS testing helps identify the autonomic basis of unexplained syncope and guide treatment decisions.

POTS

Postural Orthostatic Tachycardia Syndrome is detectable with standardized tilt and heart rate variability protocols.

Autonomic Neuropathy

Detect peripheral and autonomic neuropathy with objective, reproducible testing.

Disease Progression

Track autonomic function changes over time to monitor neurodegenerative disease progression.

Clinical Applications

Neurology and autonomic testing.

Comprehensive Autonomic Workups in Neurology

Autonomic nervous system testing is essential in neurology for evaluating unexplained syncope, orthostatic intolerance, postural orthostatic tachycardia syndrome (POTS), small fiber neuropathy, and neurodegenerative conditions like Parkinson's disease and multiple system atrophy. The American Academy of Neurology and the American Autonomic Society recommend standardized testing across all three autonomic domains — cardiovagal (parasympathetic), vasomotor adrenergic (sympathetic), and sudomotor — to establish a complete autonomic profile. VitalScan ANS+ provides neurologists with all four CPT-billable testing modalities (95921–95924) in a single 15-minute session, replacing the need for referral to specialized autonomic laboratories.

Replacing Referrals with In-Office Testing

Historically, comprehensive autonomic testing required referral to academic neurophysiology suites with tilt tables, QSART chambers, and certified technicians — creating delays of weeks to months and lost revenue for the referring practice. VitalScan ANS+ consolidates the full testing battery into a compact, automated platform that standard clinical staff can operate. CPT 95924 covers combined cardiovagal, vasomotor, and sudomotor testing, providing the highest reimbursement for a single autonomic assessment. By performing testing in-house, neurology practices capture revenue previously lost to referrals, provide faster results to patients, and generate objective data for longitudinal disease monitoring.

Nationwide Service

Serving neurology practices across the United States

US MedResources equips neurology practices nationwide with FDA-cleared autonomic and vascular diagnostic technology. From New York to Los Angeles, Chicago to Miami, practices rely on VitalScan ANS+ for early detection of neurology conditions — with CPT-billable testing that fits into a single patient visit.

Request an ROI & Quote
CPT Billing

Billable under standard CPT codes.

95924Combined autonomic testing: cardiovagal (95921), vasomotor adrenergic (95922), and sudomotor (95923) — the gold standard comprehensive workup for autonomic disorders
95921Cardiovagal innervation testing — heart rate variability during deep breathing, Valsalva, and orthostatic challenge for parasympathetic assessment
95922Vasomotor adrenergic innervation — beat-to-beat blood pressure response to tilt/standing and Valsalva, critical for syncope and orthostatic intolerance evaluation
95923Sudomotor function testing — QSART and electrochemical skin conductance for small fiber and peripheral neuropathy assessment
Revenue Projection

What it adds to your practice.

Estimated monthly revenue

3 tests/day × ~$220 avg = $13,200/month

Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.

Standardized, reproducible autonomic testing protocols
Detect POTS and orthostatic intolerance objectively
Identify autonomic basis of unexplained syncope
Track neurodegenerative disease progression
Generate automated interpretive reports
Interactive ROI Tool

Model your own patient mix.

Adjust the tests you'd run per day and your expected reimbursement for each test type. Your estimated revenue, payback period, and return on investment update instantly.

ANS Comprehensive

CPT 95924

Daily

$600

Tests per day2
Reimbursement per test300$

Sudomotor Function

CPT 95923

Daily

$180

Tests per day1
Reimbursement per test180$

Vascular (ABI / Arterial)

CPT 93922–93924

Daily

$150

Tests per day1
Reimbursement per test150$

Venous Doppler

CPT 93971

Daily

$200

Tests per day1
Reimbursement per test200$
Working days per week5
Your projected numbers

Daily gross revenue

$1,130

5 tests / day

Annual gross reimbursement

$293,800

5 days × 52 weeks

Payback period

2 mo

ROI ratio

6.5X

This mix pays back your $45,000 investment in about 2 months.

Get your personalized ROI

Illustrative model based on $45,000 promotional equipment investment and the inputs you choose. Actual reimbursement depends on medical necessity, documentation, payer policy, contracted rates, and claim adjudication. Figures are not a guarantee of reimbursement.

FAQ

Neurology autonomic testing, answered.

Can VitalScan replace a tilt table test for POTS diagnosis?

VitalScan ANS+ uses active standing protocols with beat-to-beat blood pressure and heart rate monitoring (CPT 95922) to evaluate orthostatic responses, which is the core diagnostic criterion for POTS. While a full tilt-table study may still be needed in select complex cases, VitalScan provides standardized orthostatic assessment sufficient for the majority of POTS and orthostatic intolerance evaluations — without the space, staff, and time requirements of a tilt table.

What CPT codes should neurologists use for autonomic testing?

Neurologists performing complete autonomic assessment bill CPT 95924, which covers cardiovagal (95921), vasomotor adrenergic (95922), and sudomotor (95923) testing performed together. Individual domains can be billed separately (95921, 95922, or 95923) when only partial testing is performed. Combined testing under 95924 provides the most comprehensive assessment and the highest reimbursement.

How does autonomic testing help with neurodegenerative disease?

Autonomic dysfunction is an early feature of Parkinson's disease, multiple system atrophy (MSA), pure autonomic failure (PAF), and other neurodegenerative conditions. Serial autonomic testing with VitalScan provides objective, reproducible data on disease progression and treatment response — helping neurologists differentiate MSA from Parkinson's, monitor advancing autonomic failure, and adjust management plans based on quantitative rather than subjective assessments.

Ready for your Neurology ROI analysis?

Get a personalized growth plan with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.